Fischer’s financial slump continues in Q2
Fischer Imaging of Denver continues to drift in financial doldrums. Despite increases in its second-quarter 1999 (end-July) revenues—the company posted $16.7 million for the quarter, up 9% from $15.2 million for the same period the previous
Fischer Imaging of Denver continues to drift in financial doldrums. Despite increases in its second-quarter 1999 (end-July) revenuesthe company posted $16.7 million for the quarter, up 9% from $15.2 million for the same period the previous yearFischer sustained a net loss for the quarter of approximately $2 million, including a restructuring charge. Without the charge, the companys net loss was $1.2 million, compared to $984,000 in 1998.
Fischers moderate sales growth for the period was due to increases in mammography and service revenues offset by reductions in OEM shipments, according to vice president of finance Bill Fee. Its operating results for the quarter were disappointing, Fee said: Manufacturing variances were high, while production hours were lower than the year before. The $700,000 restructuring charge occurred when Fischer discontinued a product line manufactured at one of its facilities that the company was unable to relocate to Denver. In an effort to cut operating costs, the company reduced its inventory by more than $3 million, and last month cut its staff by 5%.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
